Payer+Provider's Health System Review
March 30, 2022
The FDA on Tuesday authorized Moderna’s and Pfizer-BioNTech’s Covid-19 vaccine second booster doses for people 50 and older.
January 20, 2022
The company was launched out of stealth last year.
January 18, 2022
Last month, Pfizer reported its coronavirus antiviral drug is 89% effective at stopping hospitalizations and deaths in high-risk Covid-19 patients.
January 15, 2022
Three school districts in Massachusetts are using trained dogs to detect the coronavirus in classrooms.
January 11, 2022
None of its vaccinated employees are hospitalized for Covid, CEO Scott Kirby says.
January 8, 2022
Hospitalizations due to Covid-19 are soaring across the country at the same time that a growing number hospitals are struggling with depleted numbers of doctors, nurses and other workers.
A total of 25 cases of a strain dubbed “deltacron” have been found in that country.
December 10, 2021
The omicron variant is expected to make up more than half of all Covid cases in the U.K. by mid-December, the agency said.
November 19, 2021
The regulator said earlier that it is expected to finalize its authorization of the drug by the end of this year.
November 16, 2021
Pfizer has said its drug to treat Covid-19 reduced the risk of hospitalization or death due to the disease by 89% compared to a placebo.